Piroxicam PCD Pharma Franchise Company

Cafoli Lifecare is a WHO-GMP certified Piroxicam PCD pharma franchise company offering 4 Piroxicam formulations across Gel, Injection, Tablets. Every batch is manufactured in DCGI-approved, WHO-GMP compliant facilities and supplied to franchise partners on a monopoly basis with full promotional backing.

What is Piroxicam?

Piroxicam is a non-steroidal anti-inflammatory drug (NSAID) of the oxicam class. It inhibits the cyclo-oxygenase enzymes and thereby the synthesis of prostaglandins, producing anti-inflammatory, analgesic and antipyretic effects. Its distinguishing pharmacokinetic feature is a long plasma half-life, which allows once-daily dosing. It is used in inflammatory and degenerative joint disease and in acute musculoskeletal pain. See the compound record on PubChem.

Piroxicam Range Available for Franchise

Our Piroxicam portfolio comprises 4 formulations available in the following dosage forms: Gel, Injection, Tablets. Brand names, compositions, packing and net rates are shared on request with partners holding a valid Drug License. Contact us for the current Piroxicam price list and stock position.

Therapeutic Applications of Piroxicam

Piroxicam is indicated in osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute gout, and acute musculoskeletal injury and post-operative pain. Tablets are used for systemic therapy, the topical gel for localised joint and soft-tissue pain, and the injection for acute severe pain. Prescribers include orthopaedic surgeons, rheumatologists, physiotherapy-referring physicians, general physicians and dentists. As with all NSAIDs, it carries gastrointestinal and cardiovascular precautions and is prescription-only.

Why Piroxicam is a High-Potential Molecule for Distributors

The pain-management segment is the single largest therapeutic category by prescription volume in India, and piroxicam holds a specific position within it: once-daily dosing, driven by its long half-life, is a real adherence advantage in elderly osteoarthritis patients who are already on multiple medicines. The commercial multiplier is the three-form range — a single orthopaedic prescription often pairs an oral tablet with the topical gel, so one consultation converts into two SKUs at the chemist counter, while the injection covers acute presentations at day-care and casualty settings. For a distributor, orthopaedics is a high-frequency call cycle and piroxicam is an easy first product to place.

Why Choose Cafoli Lifecare for Your Piroxicam Franchise

Cafoli Lifecare works with over 1000+ franchise partners across India. Partners receive monopoly rights for their district or territory, WHO-GMP certified and DCGI-approved products, complete promotional inputs (visual aids, MR bags, samples, prescription pads, gifts), transparent net rates, and dependable dispatch. Our documentation and stock support are built for distributors who want to scale without operational friction.

References

1. PubChem — Piroxicam compound record (NIH / NCBI)
2. MedlinePlus — Piroxicam drug information (US National Library of Medicine)
3. PubMed — clinical literature on Piroxicam